The next generation of clinical studies with antidepressants in bipolar disorder

被引:0
|
作者
Machado-Vieira, Rodrigo [1 ,2 ]
机构
[1] Univ Sao Paulo, Inst & Dept Psychiat, LIM 27, Sao Paulo, Brazil
[2] NIMH, NIH, Bethesda, MD 20892 USA
来源
FRONTIERS IN PSYCHIATRY | 2014年 / 5卷
关键词
bipolar disorder; depression; treatment; antidepressants; biomarkers;
D O I
10.3389/fpsyt.2014.00027
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Diagnostic and clinical implications of functional neuroimaging in bipolar disorder
    Brooks, John O., III
    Vizueta, Nathalie
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 57 : 12 - 25
  • [22] Antidepressants in the treatment of bipolar depression: commentary
    Vazquez, Gustavo H.
    Baldessarini, Ross J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 (03)
  • [23] Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
    Correll, Christoph U.
    Detraux, Johan
    De Lepeleire, Jan
    De Hert, Marc
    WORLD PSYCHIATRY, 2015, 14 (02) : 119 - 136
  • [24] Antidepressants in bipolar disorder: Analysis of correlates overall, and in BD-I and BD-II subsamples
    Dell'Osso, Bernardo
    Arici, Chiara
    Cafaro, Rita
    Vismara, Matteo
    Cremaschi, Laura
    Benatti, Beatrice
    Macellaro, Monica
    Vigano, Caterina
    Ketter, Terence A.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 292 : 352 - 358
  • [25] Database of genetic studies of bipolar disorder
    Piletz, John E.
    Zhang, Xiaotong
    Ranade, Rajdeep
    Liu, Chunyu
    PSYCHIATRIC GENETICS, 2011, 21 (02) : 57 - 68
  • [26] Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: Facts or artefacts?
    Hausmann, Armand
    Hoertnagl, Christine
    Walpoth, Michaela
    Fuchs, Martin
    Conca, Andreas
    NEUROPSYCHIATRIE, 2007, 21 (02) : 131 - 158
  • [27] Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
    Mallinger, Alan G.
    Frank, Ellen
    Thase, Michael E.
    Barwell, Michelle M.
    DiazGranados, Nancy
    Luckenbaugh, David A.
    Kupfer, David J.
    PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (02) : 64 - 74
  • [28] Orexins in the clinical course of bipolar disorder
    Moya-Lacasa, C.
    Valtuena-Garcia, M.
    Martin Gil, E.
    Gonzalez-Blanco, L.
    Garcia-Portilla, M. P.
    EUROPEAN PSYCHIATRY, 2021, 64 : S623 - S623
  • [29] Clinical Characteristics Associated With Treatment-Resistant Bipolar Disorder
    Parker, Gordon B.
    Graham, Rebecca K.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2017, 205 (03) : 188 - 191
  • [30] Differential roles of adjunctive antidepressants in bipolar II compared to bipolar I disorder
    Ketter, TA
    Calabrese, JR
    Bowden, CL
    Marangell, LB
    Gyulai, L
    Wisniewski, S
    Sachs, GS
    BIPOLAR DISORDERS, 2005, 7 : 23 - 23